FDA Adverse Event Malfunction Summary report: N

COBAS 8000 C (701) MODULE

MDR report key: 6581856 · Received May 22, 2017

Report

Report Number
1823260-2017-01068
Event Type
Malfunction
Date Received
May 22, 2017
Date of Event
May 3, 2017
Report Date
May 22, 2017
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
PMA / PMN Number
K100853
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

UNIQUE IDENTIFIER (UDI)#: (B)(4). THIS EVENT OCCURRED IN (B)(6).

Description of Event or Problem · 1

THE CUSTOMER RECEIVED QUESTIONABLE LOW RESULTS FOR TWO PATIENT SAMPLES USING THE CA2 CALCIUM GEN.2 ASSAY (CA2) ON THE COBAS 8000 C (701) MODULE. ALL RESULTS ARE IN UNITS OF MMOL/L, AND ALL WERE RELEASED OUTSIDE OF THE LABORATORY TO THE CLINICIAN. PATIENT A: THE INITIAL RESULT WAS 2.02; THE REPEAT RESULT WAS 2.61. PATIENT B: THE INITIAL RESULT WAS 2.02; THE REPEAT RESULT WAS 2.59. THERE WAS NO ALLEGATION THAT AN ADVERSE EVENT OCCURRED. THE CA2 REAGENT LOT NUMBER IS 200966 WITH AN EXPIRATION DATE OF 02/28/2018. THE CUSTOMER STATED THAT NON-ROCHE QUALITY CONTROLS (QC) WERE ERRATIC ON ALL LEVELS. THE CUSTOMER WAS INSTRUCTED TO CHANGE THE SAMPLE PROBE AND RUN ROCHE QC FOR A FEW DAYS TO MONITOR RECOVERY. NO INFORMATION WAS PROVIDED TO INDICATE THAT THE CUSTOMER TOOK THESE ACTIONS. ON 05/04/2017, THE FIELD SERVICE REPRESENTATIVE REPLACED THE SAMPLE PIPETTOR FOR A SEPARATE ISSUE. THE CUSTOMER WAS CONVINCED THAT THIS ACTION RESOLVED THE ISSUE WITH QUESTIONABLE RESULTS, SINCE NON-ROCHE QC WAS NOW BACK IN RANGE. THE CUSTOMER STATED THAT THE ISSUE WAS SOLVED DUE TO MAINTENANCE AND REFUSED ADDITIONAL INVESTIGATION. A SPECIFIC ROOT CAUSE COULD NOT BE IDENTIFIED. ADDITIONAL INFORMATION FOR FURTHER INVESTIGATION WAS REQUESTED BUT WAS NOT PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
362351 COBAS 8000 C (701) MODULE CLINICAL CHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS C701 NA

Patients

Seq Age Sex Outcome Treatment
1